Niagen Bioscience (NAGE) Total Liabilities: 2011-2025
Historic Total Liabilities for Niagen Bioscience (NAGE) over the last 12 years, with Sep 2025 value amounting to $27.5 million.
- Niagen Bioscience's Total Liabilities rose 23.97% to $27.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.5 million, marking a year-over-year increase of 23.97%. This contributed to the annual value of $22.2 million for FY2024, which is 16.31% down from last year.
- Latest data reveals that Niagen Bioscience reported Total Liabilities of $27.5 million as of Q3 2025, which was up 0.49% from $27.3 million recorded in Q2 2025.
- Niagen Bioscience's 5-year Total Liabilities high stood at $27.5 million for Q3 2025, and its period low was $22.2 million during Q3 2024.
- Over the past 3 years, Niagen Bioscience's median Total Liabilities value was $26.0 million (recorded in 2025), while the average stood at $25.3 million.
- As far as peak fluctuations go, Niagen Bioscience's Total Liabilities fell by 16.31% in 2024, and later rose by 23.97% in 2025.
- Quarterly analysis of 5 years shows Niagen Bioscience's Total Liabilities stood at $26.1 million in 2021, then declined by 2.79% to $25.4 million in 2022, then rose by 4.42% to $26.5 million in 2023, then declined by 16.31% to $22.2 million in 2024, then climbed by 23.97% to $27.5 million in 2025.
- Its last three reported values are $27.5 million in Q3 2025, $27.3 million for Q2 2025, and $26.0 million during Q1 2025.